CD274 and non-small cell lung carcinoma: PD‐L1‐positive lung tumors show significantly lower numbers of tumor infiltrating lymphocytes (TILs) when compared to PD‐L1‐negative lung tumors, which suggests that PD‐L1 expression in tumor cells may contribute to the negative regulation of the antitumor immune response in NSCLC 4.